Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00114517 · ClinicalTrials.gov registry record · Phase 2
ELITE: Early Versus Late Intervention Trial With Estradiol
A Phase 2 study, sponsored by University of Southern California.
- Completed
- Registry status
- Phase 2
- Development phase
- 643
- Enrollment target
NCT00114517: Completed Phase 2 study, sponsored by University of Southern California.
NCT00114517 is a Phase 2 study that has completed, run by University of Southern California. The registered enrollment target is 643 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (383% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00114517, a Phase 2 study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 643 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of oral 17B-estradiol (estrogen) on the progression of early (subclinical) atherosclerosis and cognitive decline in healthy postmenopausal women.
Primary Outcome
Rate of change in distal common carotid artery (CCA) far wall intima-media thickness (mm per year) in computer image processed B-mode ultrasonograms that were obtained at two baseline examinations (averaged to obtain the baseline CIMT value) and every 6 months during trial follow-up.
Interventions
- OTHER Placebo
- DRUG 17B-estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 643 participants |
| Start Date | 2004-07 |
| Est. Completion | 2013-03-05 |
| Phase | Phase 2 |
What the finished NCT00114517 record still lists
NCT00114517 is an interventional study that assigns participants to a tested intervention. The registered 643 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (383% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00114517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00114517 about?
NCT00114517 is a clinical study titled "ELITE: Early Versus Late Intervention Trial With Estradiol". The purpose of this study is to examine the effects of oral 17B-estradiol (estrogen) on the progression of early (subclinical) atherosclerosis and cognitive decline in healthy postmenopausal women.
What is the current status of trial NCT00114517?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 643 participants. The study started on 2004-07. Estimated completion is 2013-03-05.
What interventions are being tested in trial NCT00114517?
The interventions under investigation include: Placebo (OTHER), 17B-estradiol (DRUG).
Who is sponsoring clinical trial NCT00114517?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00114517's enrollment target sits among peer trials
643 50th of 2000 higher than 1,951 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05146297 · 644 participants · NA
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
- NCT06994442 · 644 participants · Phase 3
Optimizing Pain Treatment in Children On Mechanical Ventilation
- NCT05204888 · 642 participants · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- NCT07012395 · 645 participants · Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia